GlassScriptPrepare for your visit
Madhu Chaudhry
Medical Oncology · Baltimore, MD · NPI 1447201678
One page to bring to your appointment. Every figure is as reported to CMS by drug and device makers. Payments are legal and often routine; this is context for a conversation, not a verdict.
What was reported
$3,384.28
in general payments reported to CMS, 2019-2025 · $898 in 2025
The $898 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Who reported paying
General payments only, top 6 by amount.
- Grifols Shared Services North America, INC. $1,006.65
- Pfizer INC. $233.35
- Astrazeneca Pharmaceuticals LP $173.55
- Novartis Pharmaceuticals Corporation $170.13
- Adc Therapeutics America, INC. $164.76
- Merck Sharp & Dohme LLC $131.59
Drugs and devices associated with these payments
Gamunex-C Rystiggo Tukysa Keytruda Kisqali Ibrance Adcetris Xt Cdx Enhertu Xtandi Talzenna Braftovi
Association is not allocation: a product listed here means a payment was associated with it, not that money was paid to promote it. Detail covers 2023-2025.
Questions you might ask
- I saw Madhu Chaudhry listed in the CMS Open Payments database. Can you tell me about your work with those companies?
- Is there a generic or alternative to this medication, and would it work as well for me?
- What made you choose this particular treatment for my situation?
These are normal questions. A good clinician will welcome them.
Notes
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.
GlassScript is independent and not affiliated with CMS or any government agency. glasscript.com/doctor/201542/madhu-chaudhry